Is Mini-Gastric Bypass a Rational Approach for Type-2 Diabetes?

Overview

Journal Curr Atheroscler Rep

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2017 Oct 25

PMID 29063974

Citations 8

Authors

Reem Abou Ghazaleh

Matthieu Bruzzi

Karen Bertrand

Leila MHarzi

Franck Zinzindohoue

Richard Douard

Anne Berger

Sebastien Czernichow

Claire Carette

Jean-Marc Chevallier

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Morbid obesity and type-2 diabetes mellitus (T2DM) are both major public health problems. Bariatric surgery is a proven and effective treatment for these conditions; laparoscopic Roux-en-Y gastric bypass (RYGB) is currently the gold-standard treatment. One-anastomosis gastric bypass (OAGB) is described as a simpler, safer, and non-inferior alternative to RYGB to treat morbid obesity. Concerning T2DM, experts of the OAGB procedure report promising metabolic results with good long-term remission of T2DM; however, heterogeneity within the literature prompted us to analyze this issue.

Recent Findings: OAGB has gained popularity given its safety and long-term efficacy. Concerning the effect of OAGB for the treatment of T2DM, most reports involve non-controlled single-arm studies with heterogeneous methodologies and a few randomized controlled trials. However, this available literature supports the efficacy of OAGB for remission of T2DM in obese and non-obese patients. Two years after OAGB, the T2DM remission and improvement rate increased from 67 to 100%. The results were improved and stable in the long term. The 5-year T2DM remission rate increased from 82 to 84.4%. OAGB is non-inferior compared with RYGB and even superior to other accepted bariatric procedures, such as sleeve gastrectomy and adjustable gastric banding. OAGB is an efficient, safe, simple, and reversible procedure to treat T2DM. The literature reveals interesting results for T2DM remission in non-obese patients. High-level comparative studies are required to support these data.

Citing Articles

Surgical management of gallstone ileus after one anastomosis gastric bypass: A case report.

El Feghali E, Akel R, Chamaa B, Kazan D, Chakhtoura G World J Gastrointest Surg. 2023; 15(9):2083-2088.

PMID: 37901746 PMC: 10600774. DOI: 10.4240/wjgs.v15.i9.2083.

One anastomosis gastric bypass surgery in Type2 diabetes patients with body mass index < 35 kg/m: A multi-center retrospective cohort study.

Amirbeigi A, Abbaslou F, Talebpour M, Soroush A, Elyasinia F, Mahmoudabadi H Ann Med Surg (Lond). 2022; 79:104102.

PMID: 35860068 PMC: 9289504. DOI: 10.1016/j.amsu.2022.104102.

Remission of Type II Diabetes Mellitus 1-Year Postoperative Following One Anastomosis Gastric Bypass in Correlation with ABCD, DiaRem, and DRS Scores.

Eskandaros M, Abbass A, Ebeid E, Darwish A Obes Surg. 2021; 32(2):450-456.

PMID: 34780027 DOI: 10.1007/s11695-021-05793-0.

Imaging features in management of laparoscopic mini/one anastomosis gastric bypass post-surgical complications.

Scavone G, Castelli F, Caltabiano D, Raciti M, Ini C, Basile A Heliyon. 2021; 7(8):e07705.

PMID: 34401586 PMC: 8353499. DOI: 10.1016/j.heliyon.2021.e07705.

IFSO Update Position Statement on One Anastomosis Gastric Bypass (OAGB).

De Luca M, Piatto G, Merola G, Himpens J, Chevallier J, Carbajo M Obes Surg. 2021; 31(7):3251-3278.

PMID: 33939059 DOI: 10.1007/s11695-021-05413-x.

References

Wang W, Wei P, Lee Y, Huang M, Chiu C, Lee W . Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005; 15(5):648-54. DOI: 10.1381/0960892053923752. View

Wittgrove A, Clark G . Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up. Obes Surg. 2000; 10(3):233-9. DOI: 10.1381/096089200321643511. View

Rutledge R, Walsh T . Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005; 15(9):1304-8. DOI: 10.1381/096089205774512663. View

Lee W, Lin Y . Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence. Obes Surg. 2014; 24(10):1749-56. DOI: 10.1007/s11695-014-1369-9. View

Quan Y, Huang A, Ye M, Xu M, Zhuang B, Zhang P . Efficacy of Laparoscopic Mini Gastric Bypass for Obesity and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2015; 2015:152852. PMC: 4488176. DOI: 10.1155/2015/152852. View

Garcia-Caballero M, Valle M, Martinez-Moreno J, Miralles F, Toval J, Mata J . Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with One Anastomosis Gastric Bypass. Nutr Hosp. 2012; 27(2):623-31. DOI: 10.1590/S0212-16112012000200041. View

Rubino F . Medical research: Time to think differently about diabetes. Nature. 2016; 533(7604):459-61. DOI: 10.1038/533459a. View

Noun R, Riachi E, Zeidan S, Abboud B, Chalhoub V, Yazigi A . Mini-gastric bypass by mini-laparotomy: a cost-effective alternative in the laparoscopic era. Obes Surg. 2008; 17(11):1482-6. DOI: 10.1007/s11695-008-9426-x. View

Lee W, Chong K, Lin Y, Wei J, Chen S . Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014; 24(9):1552-62. DOI: 10.1007/s11695-014-1344-5. View

10.

Bruzzi M, Rau C, Voron T, Guenzi M, Berger A, Chevallier J . Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis. 2015; 11(2):321-6. DOI: 10.1016/j.soard.2014.09.004. View

11.

Schauer P, Bhatt D, Kirwan J, Wolski K, Brethauer S, Navaneethan S . Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014; 370(21):2002-13. PMC: 5451259. DOI: 10.1056/NEJMoa1401329. View

12.

Rutledge R . The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001; 11(3):276-80. DOI: 10.1381/096089201321336584. View

13.

Rubino F, Marescaux J . Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2003; 239(1):1-11. PMC: 1356185. DOI: 10.1097/01.sla.0000102989.54824.fc. View

14.

Lee W, Ser K, Lee Y, Tsou J, Chen S, Chen J . Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012; 22(12):1827-34. DOI: 10.1007/s11695-012-0726-9. View

15.

Zubiaga L, Abad R, Ruiz-Tovar J, Enriquez P, Vilchez J, Calzada M . The Effects of One-Anastomosis Gastric Bypass on Glucose Metabolism in Goto-Kakizaki Rats. Obes Surg. 2016; 26(11):2622-2628. DOI: 10.1007/s11695-016-2138-8. View

16.

Carbajo M, Garcia-Caballero M, Toledano M, Osorio D, Garcia-Lanza C, Carmona J . One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005; 15(3):398-404. DOI: 10.1381/0960892053576677. View

17.

Guenzi M, Arman G, Rau C, Cordun C, Moszkowicz D, Voron T . Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity. Surg Endosc. 2015; 29(9):2669-74. DOI: 10.1007/s00464-014-3987-7. View

18.

Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J . The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004; 240(2):236-42. PMC: 1356398. DOI: 10.1097/01.sla.0000133117.12646.48. View

19.

Buchwald H, Oien D . Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013; 23(4):427-36. DOI: 10.1007/s11695-012-0864-0. View

20.

Nguyen N, Varela J . Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2016; 14(3):160-169. DOI: 10.1038/nrgastro.2016.170. View